demonstrated that the enhanced EMT process associated with cisplatin resistance in ovarian cancer was strongly linked to increased phosphorylation of epidermal growth factor receptor (EGFR) due to PDK1 overexpression.18 This evidence concerns the gene EGFR and ovarian cancer.